| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |